Page last updated: 2024-08-20

dibenzo(a,l)pyrene and nu 7026

dibenzo(a,l)pyrene has been researched along with nu 7026 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ferlińska, M; Nocuń, M; Roszak, J; Smok-Pieniążek, A; Spryszyńska, S; Stępnik, M1
Brodecki, M; Domeradzka Gajda, K; Kowalczyk, K; Roszak, J; Sobańska, Z; Stępnik, M; Szparaga, M1

Other Studies

2 other study(ies) available for dibenzo(a,l)pyrene and nu 7026

ArticleYear
The influence of ATM, ATR, DNA-PK inhibitors on the cytotoxic and genotoxic effects of dibenzo[def,p]chrysene on human hepatocellular cancer cell line HepG2.
    Mutation research. Genetic toxicology and environmental mutagenesis, 2015, Volume: 791

    Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Benzopyrenes; Caffeine; Cell Proliferation; Chromones; Cytotoxins; DNA Breaks, Single-Stranded; DNA-Activated Protein Kinase; Hep G2 Cells; Humans; Morpholines; Mutagens; Protein Kinase Inhibitors; Pyrones; Reactive Oxygen Species

2015
The effect of inhibitors of phosphatidylinositol 3-kinase-related kinases on dibenzo[def,p]chrysene genotoxicity measured by γH2AX levels and neutral comet assay in HepG2 human hepatocellular cancer cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2020, Volume: 63

    Topics: Benzopyrenes; Carcinoma, Hepatocellular; Cell Survival; Chromones; Comet Assay; DNA Damage; Hep G2 Cells; Histones; Humans; Liver Neoplasms; Morpholines; Phosphatidylinositol 3-Kinase; Protein Kinase Inhibitors

2020